Targeting Lifestyle Behavior Change in Adults with NAFLD During a 20-min Consultation: Summary of the Dietary and Exercise Literature

Current Gastroenterology Reports

Volumn 18, Issue 3, 2016, Pages 1-7

  Hallsworth, Kate ^a   Avery, Leah ^a   Trenell, Michael I ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Behavior change; Diet; Exercise; Non alcoholic fatty liver disease (NAFLD); Physical activity; Weight loss

Indexed keywords

BEHAVIOR CHANGE; CARDIOVASCULAR RISK; CONSULTATION; DIETARY INTAKE; EVIDENCE BASED MEDICINE; EXERCISE; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; LIFESTYLE MODIFICATION; NONALCOHOLIC FATTY LIVER; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; REVIEW; SEDENTARY LIFESTYLE; WEIGHT REDUCTION; HEALTH BEHAVIOR; LIFESTYLE; LOW CALORY DIET; NON-ALCOHOLIC FATTY LIVER DISEASE; PATIENT EDUCATION; PROCEDURES;

DIET, REDUCING; EXERCISE; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; NON-ALCOHOLIC FATTY LIVER DISEASE; PATIENT EDUCATION AS TOPIC; WEIGHT LOSS;

EID: 84959372436     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-016-0485-1     Document Type: Review

References (52)

1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatol. 2004;40:1387–95.
2. Smits MM, Ioannou GN, Boyko EJ, Utzschneider KM. Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups. J Gastroenterol Hepatol. 2013;28:664–70.
3. Day CP. Non-alcoholic fatty liver disease: current concepts and management strategies. Clin Med, J R Coll Physicians. 2006;6:19–25.
4. Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nature Reviews Gastroenterology and Hepatology 2013;10. This article reviews the evidence that suggests NAFLD is a multisystem disease and the factors that might determine interindividual variation in the development and progression of its major hepatic and extrahepatic manifestations (principally Type 2 diabetes mellitus and cardiovascular disease).
5. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterol. 1999;116:1413–9.
6. Ratziu V, Bellentani S, Cortez-Pinto H, Day CP, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010;53:372–84.
7. Loria P, Adinolfi LE, Bellentani S, Bugianesi E, Grieco A, Fargion S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease: a decalogue from the Italian Association for the Study of the Liver (AISF) expert committee. Digestive and Liver Disease. 2010;42:272–82.
8. Williams R, Ashton K, Aspinall R, Bellis M, Bosanquet J, Cramp M, et al. Implementation of the Lancet Standing Commission on Liver Disease in the UK. Lancet. 2015;386:2098–111.
9. Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol. 2012;56:255–66. This systematic review provides evidence that lifestyle interventions designed to reduce energy intake and/or increase energy expenditure reduce liver fat and improve insulin sensitivity in patients with NAFLD.
10. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes. 2005;54:603–8.
11. Kirk E, Reeds DN, Finck BN, Mayurranjan MS, Patterson BW, Klein S. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterol. 2009;136:1552–60.
12. Viljanen APM, Iozzo P, Borra R, Kankaanpää M, Karmi A, Lautamäki R, et al. Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance. J Clin Endocrinol Metabolism. 2009;94:50–5.
13. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterol. 2015;149:367–78.
14. Sreenivasa Baba C, Alexander G, Kalyani B, Pandey R, Rastogi S, Pandey A, et al. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol. 2006;21:191–8.
15. Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW, et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatol. 2009;50:1105–12.
16. Hallsworth K, Thoma C, Hollingsworth KG, Cassidy S, Anstee QM, Day CP, et al. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial. Clin Sci. 2015;129:1097–105.
17. Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut. 2011;60:1278–83.
18. Oza N, Eguchi Y, Mizuta T, Ishibashi E, Kitajima Y, Horie H, et al. A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff. J Gastroenterol. 2009;44:1203–8.
19. Albu JB, Heilbronn LK, Kelley DE, Smith SR, Azuma K, Berk ES, et al. Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes. 2010;59:627–33.
20. Promrat K, Kleiner DE, Niemeier H, Jackvony E, Kearns M, Wands JR, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatol. 2010;51:121–9.
21. Dyson J, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to treatment. Frontline Gastroenterol. 2014;5:277–86.
22. Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial. Hepatol. 2009;49:80–6.
23. Department of Health. UK Physical Activity Guidelines. In: Department of Health; 2011.
24. ACSM. American College of Sports Medicine Position Stand. Appropriate physical activity intervention for weight loss and weight regain for adults. Med Sci Sports and Exercise. 2009;41:459–71.
25. Morris JN, Heady JA, Raffle PA, Roberts CG, Parks JW. Coronary heart-disease and physical activity of work. Lancet. 1953;265:1053–7.
26. Jonker JT, De Laet C, Franco OH, Peeters A, Mackenbach J, Nusselder WJ. Physical activity and life expectancy with and without diabetes: life table analysis of the Framingham heart study. Diabetes Care. 2006;29:38–43.
27. Healy GN, Wijndaele K, Dunstan DW, Shaw JE, Salmon J, Zimmet PZ, et al. Objectively measured sedentary time, physical activity, and metabolic risk: the Australian diabetes, obesity and lifestyle study (AusDiab). Diabetes Care. 2008;31:369–71.
28. Autenrieth C, Baumert J, Baumeister S, Fischer B, Peters A, Döring A, et al. Association between domains of physical activity and all-cause, cardiovascular and cancer mortality. European J Epidemiol. 2011;26:91–9.
29. Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A, et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. New England Journal of Medicine. 2002;347:716–25.
30. Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Exercise type and intensity in relation to coronary heart disease in men. JAMA. 2002;288:1994–2000.
31. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.
32. DPP. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
33. Friedenreich CM. Physical activity and cancer prevention. Cancer Epidem Biomark Prev. 2001;10:287–301.
34. Hallsworth K, Thoma C, Moore S, Ploetz T, Anstee QM, Taylor R, et al. Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behavior and lower levels of physical activity than matched healthy controls. Frontline Gastroenterol. 2015;6:44–51. This was the first study to objectively measure sedentary behavior and physical activity in people with NAFLD and investigated links between physical activity levels, liver fat, and glucose control.
35. Perseghin G, Lattuada G, De Cobelli F, Ragogna F, Ntali G, Esposito A, et al. Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes Care. 2007;30:683–8.
36. NICE. NICE Clinical Guidelines. CG43 Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. Care NIfHaCEaNCCfP, ed. 2006.
37. Ferolla SM, Silva LC, Ferrari Mde L, da Cunha AS, Martins Fdos S, Couto CA, et al. Dietary approach in the treatment of nonalcoholic fatty liver disease. World J Hepatol. 2015;7:2522–34.
38. Basaranoglu M, Basaranoglu G, Bugianesi E. Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary Surg Nutr. 2015;4:109–16.
39. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatol. 2010;51:1961–71.
40. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Zvibel I, Goldiner I, et al. Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study. Hepatol. 2008;48:1791–8.
41. Cassidy S, Thoma C, Hallsworth K, Parikh J, Hollingsworth K, Taylor R, et al. High intensity intermittent exercise improves cardiac structure and function and reduces liver fat in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2015:1-11.
42. Keating SE, Hackett DA, Parker HM, O’Connor HT, Gerofi JA, Sainsbury A, et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. Journal of Hepatology. 2015;63:174–82. This study found no difference in efficacy of liver fat reduction by either aerobic exercise dose or intensity. All of the aerobic exercise regimens employed reduced liver fat and VAT by a small amount without clinically significant weight loss.
43. Oh S, Shida T, Yamagishi K, Tanaka K, So R, Tsujimoto T, et al. Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: a retrospective study. Hepatology. 2015;61:1205–15.
44. Bravata DM, Smith-Spanger C, Sundaram V, Gienger AL, Lin N, Lewis R, et al. Using pedometers to increase physical activity and improve health: systematic review. JAMA. 2007;298:2296–304.
45. Michie S, Ashford S, Sniehotta F, Dombrowski S, Bishop A, French D. A refined taxonomy of behavior change techniques to help people change their physical activity and healthy eating behaviors: the CALO-RE taxonomy. Psychol Health. 2011;26:1479–98.
46. Rollnick S, Mason P. Health behavior change: a guide for practitioners. London: Elsevier; 1999.
47. Avery L, Flynn D, van Wersch A, Sniehotta FF, Trenell MI. Changing physical activity behavior in type 2 diabetes: a systematic review and meta-analysis of behavioral interventions. Diabetes Care. 2012;35(12):2681–9. Diabetes Care 2012;35:2681-2689. This review identified a number of behavior change techniques delivered in clinical and community settings that are associated with increases in physical activity behavior and improvements in glycaemic control in people who are overweight or obese with Type 2 diabetes.
48. Avery L, Flynn D, Dombrowski SU, Wan Wersch A, Sniehotta FF, Trenell MI. Successful behavioral strategies to increase physical activity and improve glucose control in adults with type 2 diabetes. Diabetic Medicine. 2015;32:1058–62.
49. French DP, Stevenson A, Michie S. An intervention to increase walking requires both motivational and volitional components: a replication and extension. Psychol Health Med. 2012;17:127–35.
50. Greaves CJ, Sheppard KE, Abraham C, Hardeman W, Roden M, Evans PH, et al. Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions. BMC Public Health. 2011;11:119.
51. Sniehotta F, Scholz U, Schwarzer R. Action plans and coping plans for physical exercise: a longitudinal intervention study in cardiac rehabilitation. Br J Health Psychol. 2006;11:23–37.
52. Kwasnicka D, Presseau J, White M, Sniehotta F. Does planning how to cope with anticipated barriers facilitate health-related behavior change? A systematic review. Health Psychol Rev. 2013;7:129–45.